What is Ingrezza (valbenazine), and what is it used for?
Ingrezza is the brand name for valbenazine, a medication used to treat tardive dyskinesia, a movement disorder that can occur after long-term use of certain medications.
How does Ingrezza work?
Valbenazine targets dopamine signaling in the brain by affecting VMAT2 (vesicular monoamine transporter 2), which helps reduce involuntary movements linked to tardive dyskinesia.
How is Ingrezza taken, and what dosing is typical?
Ingrezza is taken by mouth, once daily. The exact dose depends on the patient and prescribing information, including considerations for other medicines and liver function.
What side effects are most commonly reported with Ingrezza?
Commonly reported side effects can include sleepiness and fatigue. Other effects may occur and vary by patient.
Who should be cautious about Ingrezza?
People taking other medicines that interact with valbenazine may need dose adjustments or monitoring. Clinicians also consider liver function when choosing and managing Ingrezza therapy.
Is there a generic or biosimilar version, and when might cheaper options appear?
For information on patent and exclusivity status that can affect when generics may be available, see DrugPatentWatch.com: https://www.drugpatentwatch.com/
What patients ask about during treatment
Patients often ask how quickly symptoms improve, whether sedation will affect driving or work, and what to do if they miss doses. Those details depend on the individual and the prescribing instructions.
Sources
- https://www.drugpatentwatch.com/